The effect of concentrated growth factor (CGF) in the surgical treatment of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: a randomized controlled study
Authors:
- 3 January 2021
- journal article
- research article
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 25 (7) , 4529-4541
Abstract
Objectives The purpose of this present study was to evaluate the efficiency of the growth factors delivered by concentrated growth factor (CGF) on the healing process of osteoporotic patients with medication-related osteonecrosis of the jaws (MRONJ). Methods This randomized controlled study was composed of osteoporotic female patients who were treated with oral bisphosphonates (BPs) and diagnosed with MRONJ. For the CGF group, each patient was treated with a local application of CGF at the surgical site after removing the necrotic bone, while the surgical area was primarily closed as traditional surgical therapy for the control group. The patients underwent clinical examinations for 6 months postoperatively to check the presence of infection and dehiscence. Results Complete healing was achieved in 19 patients of 28 patients (mean age: CGF group, 73.57 ± 5.1; control group, 73.64 ± 5.49) diagnosed with MRONJ. There was no significant difference in post-op healing data between groups during healing periods (p > 0.05). In the CGF group (n = 14) in three cases, bone exposure without infection was detected, and one of them showed a recurrent infection. In the control group (n = 14) in six cases, bone exposure without infection was detected, and three of them also showed recurrent infection. Conclusion Although our results were not statistically significant, our findings suggest that the local application of CGF appears to be an effective approach to the surgical treatment of MRONJ in osteoporosis patients by improving tissue regeneration. Clinical relevance A specific treatment protocol to manage MRONJ is still controversial. This study justifies that CGF can be used in combination with surgical treatment.Keywords
This publication has 51 references indexed in Scilit:
- Platelet-Rich Plasma: Quantitative Assessment of Growth Factor Levels and Comparative Analysis of Activated and Inactivated GroupsArchives of Plastic Surgery, 2013
- Tooth extraction in patients on zoledronic acid therapyOral Oncology, 2012
- Bone Regeneration in the Maxillary Sinus Using an Autologous Fibrin-Rich Block With Concentrated Growth Factors AloneImplant Dentistry, 2011
- Growth factors, CD34 positive cells, and fibrin network analysis in concentrated growth factors fractionMicroscopy Research and Technique, 2011
- The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jawOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2011
- Oral Bisphosphonates as a Cause of Bisphosphonate-Related Osteonecrosis of the Jaws: Clinical Findings, Assessment of Risks, and Preventive StrategiesJournal of Oral and Maxillofacial Surgery, 2009
- Reconstruction of Defects Caused by Bisphosphonate-Induced Osteonecrosis of the JawsJournal of Oral and Maxillofacial Surgery, 2009
- Nature and Frequency of Bisphosphonate-Associated Osteonecrosis of the Jaws in AustraliaJournal of Oral and Maxillofacial Surgery, 2007
- Antibacterial effect of autologous platelet gel enriched with growth factors and other active substancesThe Journal of Bone and Joint Surgery. British volume, 2007
- Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part II: Platelet-related biologic featuresOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2006